Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07037888 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
A Phase 4 study of Hip Arthroscopy and Femoracetabular Impingement, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07037888 is a Phase 4 study of Hip Arthroscopy and Femoracetabular Impingement that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 100 participants, below the 1,117-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07037888, a Phase 4 study of Hip Arthroscopy and Femoracetabular Impingement, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether the medication ketorolac can help manage pain after hip arthroscopy as well or better than the standard opioid-based pain medications. This study focuses on adult patients (over 18 years old) undergoing hip arthroscopy at Henry Ford Health System in Detroit, Michigan. Both men and women are included, and all participants must be able to consent and communicate in English. The main questions it aims to answer are: Can ketorolac help control pain as effectively or better than opioids after hip arthroscopy? Will ketorolac use reduce the amount of opioid medication needed after surgery? Researchers will compare the group receiving ketorolac to the group receiving standard opioid pain medications to see if ketorolac reduces pain and opioid use after surgery. Participants will: Be randomly assigned to one of two groups: The control group, which receives the current standard pain management protocol (hydrocodone-acetaminophen and diazepam) The experimental group, which receives the same protocol plus ketorolac and a stomach-protecting medication (omeprazole) Receive their assigned pain medications after hip arthroscopy Be asked to: Take the prescribed medications after discharge Complete a pain journal for 5 days following surgery, documenting pain levels and any side effects Complete follow-up surveys and assessments at 2 weeks, 6 weeks, and 3 months after surgery The main measurement researchers will use is the Visual Analog Scale (VAS) for pain on post-operative day 4. Additional measures include how many narcotic pills are used and results from PROMIS physical function and pain interference scores. The hope is that ketorolac will provide equal or better pain control without the risks of addiction and side effects associated with opioid medications. If successful, this approach could offer a safer alternative for managing pain after hip arthroscopy. Participants may personally benefit by having effective
Conditions Studied
Interventions
- DRUG Ketorolac
- DRUG Omeprazole
- DRUG Control (Standard treatment)
Study Locations (1)
Michigan
- Henry Ford Health - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07037888
The ClinicalTrials.gov registry entry for NCT07037888 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (91% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hip Arthroscopy appearing as the primary indexed condition, and to 3 interventions - of which Ketorolac is the first listed.
NCT07037888 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07037888 about?
NCT07037888 is a clinical study titled "Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial". The goal of this clinical trial is to learn whether the medication ketorolac can help manage pain after hip arthroscopy as well or better than the standard opioid-based pain medications. This study focuses on adult patients (over 18 years old) undergoing hip arthroscopy at Henry Ford Health System i...
What is the current status of trial NCT07037888?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2023-12-13. Estimated completion is 2026-12.
What conditions does trial NCT07037888 study?
This clinical trial studies the following conditions: Hip Arthroscopy, Femoracetabular Impingement.
What interventions are being tested in trial NCT07037888?
The interventions under investigation include: Ketorolac (DRUG), Omeprazole (DRUG), Control (Standard treatment) (DRUG).
Who is sponsoring clinical trial NCT07037888?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07037888 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Arthroscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
RECRUITING · Phase 4
-
Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
RECRUITING · NA
-
Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery
RECRUITING · Phase 2
-
An Evaluation of Hip Preservation Outcomes
RECRUITING
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
Effect of Post-operative Brace on Pain and Patient Outcomes Following Hip Arthroscopy for FAIS
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.